Concepedia
Statistics
Publications
114
Citations
10.9K
H-Index
34
Active since
1996
Affiliations
University of Debrecen(Current)
University Hospital Hradec Králové
Charles University
The Maria Sklodowska-Curie National Research Institute of Oncology
The University of Texas MD Anderson Cancer Center
Árpád Illés is an author at University of Debrecen specializing in medicine, oncology, and hematologic malignancy therapy.
Publications per year
1996–2025
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat et al. · New England Journal of Medicine · 2020 · 2.8K citations · Full text
Medicine, Pharmacotherapy, Medical Oncology +3
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 764 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text
Medicine, Hematology, Oncology +12
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · The Lancet · 2019 · 636 citations
Medicine, Hematology, Pharmacotherapy +15
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 635 citations · Full text
Medicine, Oncology, Pharmacology +10
1–5 of 114